CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
47.07
+0.38 (0.81%)
Aug 10, 2026, 4:00 PM EDT - Market closed
CareDx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 373.64 | 65.43 | 114.69 | 82.2 | 89.92 | 348.49 |
Short-Term Investments | - | 111.78 | 145.96 | 153.22 | 203.17 | - |
Cash & Short-Term Investments | 373.64 | 177.21 | 260.65 | 235.42 | 293.09 | 348.49 |
Cash Growth | 100.61% | -32.01% | 10.72% | -19.68% | -15.90% | 55.09% |
Accounts Receivable | 34.38 | 42.63 | 64.61 | 51.06 | 66.31 | 59.76 |
Inventory | - | 26.71 | 19.5 | 19.47 | 19.23 | 17.19 |
Other Current Assets | 14.23 | 10.59 | 7.07 | 7.76 | 9.22 | 7.93 |
Total Current Assets | 429.22 | 257.13 | 351.83 | 313.71 | 387.85 | 433.36 |
Net Property, Plant & Equipment | 43.04 | 55.73 | 57.89 | 65.14 | 70.22 | 40.04 |
Other Intangible Assets | 18.56 | 31.96 | 38.18 | 45.7 | 43.05 | 50.2 |
Goodwill | 35.97 | 40.34 | 40.34 | 40.34 | 37.52 | 36.98 |
Long-Term Investments | - | 24.17 | - | - | - | - |
Other Long-Term Assets | 6.2 | 3.9 | 2.81 | 1.94 | 4.35 | 6.05 |
Total Assets | 532.99 | 413.23 | 491.05 | 466.83 | 542.99 | 566.62 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 9.49 | 9.99 | 7.69 | 12.87 | 9.94 | 13.34 |
Accrued Expenses | 84.21 | 79.86 | 81.69 | 65.2 | 66.03 | 63.96 |
Total Current Liabilities | 93.7 | 89.85 | 89.37 | 78.07 | 75.98 | 77.3 |
Long-Term Leases | 13.2 | 19.68 | 22.26 | 28.28 | 33.41 | 17.39 |
Other Long-Term Liabilities | 0.49 | 0.6 | 0.98 | 99.15 | 2.7 | 6.05 |
Total Long-Term Liabilities | 13.69 | 20.28 | 23.25 | 127.43 | 36.11 | 23.44 |
Total Liabilities | 107.39 | 110.13 | 112.62 | 205.5 | 112.08 | 100.75 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Additional Paid-in Capital | 930.99 | 1,044 | 1,013 | 946.51 | 898.81 | 853.68 |
Accumulated Other Comprehensive Income | - | -5.52 | -8.57 | -6.96 | -7.5 | -4.67 |
Retained Earnings | -505.45 | -735.36 | -626.24 | -678.27 | -460.44 | -383.19 |
Shareholders' Equity | 425.6 | 303.1 | 378.43 | 261.33 | 430.91 | 465.88 |
Total Liabilities & Equity | 532.99 | 413.23 | 491.05 | 466.83 | 542.99 | 566.62 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13.2 | 19.68 | 22.26 | 28.28 | 33.41 | 17.39 |
Net Cash (Debt) | 360.44 | 157.53 | 238.39 | 207.14 | 259.68 | 331.09 |
Net Cash Growth | 120.48% | -33.92% | 15.09% | -20.23% | -21.57% | 58.70% |
Net Cash Per Share | 6.82 | 2.96 | 4.21 | 3.85 | 4.87 | 6.34 |
Book Value | 425.6 | 303.1 | 378.43 | 261.33 | 430.91 | 465.88 |
Book Value Per Share | 8.05 | 5.69 | 6.68 | 4.86 | 8.08 | 8.92 |
Tangible Book Value | 371.07 | 230.81 | 299.91 | 175.29 | 350.34 | 378.7 |
Tangible Book Value Per Share | 7.02 | 4.33 | 5.30 | 3.26 | 6.57 | 7.25 |